We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ACCUSED OF GRANTING TOO MANY WAIVERS TO PANEL MEMBERS
FDA ACCUSED OF GRANTING TOO MANY WAIVERS TO PANEL MEMBERS
February 9, 2004
Although the FDA’s Psychopharmacologic Advisory Committee recently took a stand in favor of stronger warnings regarding the possible increased suicide risk in children using antidepressants, a health advocacy group wants the agency to remove three committee members who have done research, consulting and other work for manufacturers of those drugs.